Stock Scorer

biote Corp. (BTMD)

biote Corp. reported revenue of 44.2M USD for the quarter ending 30 June 2026, down 9.5% from 48.9M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 44.2M -9.5%
Gross Profit Q2 '26 · ending 30 June 2026 28M -18.0%
Operating Income Q2 '26 · ending 30 June 2026 -3.5M -132.6%
Net Income Q2 '26 · ending 30 June 2026 -6.6M -306.1%
Cost of Revenue Q2 '26 · ending 30 June 2026 15.3M +10.4%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -1.2M -116.6%
Free Cash Flow Q2 '26 · ending 30 June 2026 -3.7M -170.7%
Shares Outstanding Q2 '26 · ending 30 June 2026 28.6M -22.5%
EPS Q2 '26 · ending 30 June 2026 0.11 -87.6%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 192.2M35.6M27M30.2M
20242024-12-31 197.2M31.6M3.2M38.8M
20232023-12-31 185.4M28.7M3.3M26.5M
20222022-12-31 165M-60.7M-969K-9.5M
20212021-12-31 139.4M34.6M11.1M32.3M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-3044.2M
Q1 '262026-03-3144.9M
Q4 '252025-12-3146.4M
Q3 '252025-09-3048M
Q2 '252025-06-3048.9M
Q1 '252025-03-3149M
Q4 '242024-12-3149.8M
Q3 '242024-09-3051.4M
Q2 '242024-06-3049.2M
Q1 '242024-03-3146.8M
Q4 '232023-12-3145.7M
Q3 '232023-09-3045.6M
Q2 '232023-06-3049.3M
Q1 '232023-03-3144.8M
Q4 '222022-12-3144.5M
Q3 '222022-09-3042M
Q2 '222022-06-3041.4M
Q1 '222022-03-3137.1M
Q4 '212021-12-3137.5M
Q3 '212021-09-3035.6M

Gross Profit Quarterly

Revenue minus cost of sales. This filer tags no gross profit of its own..

PeriodEndingGross Profit
Q2 '262026-06-3028M
Q1 '262026-03-3130M
Q4 '252025-12-3130.6M
Q3 '252025-09-3033.5M
Q2 '252025-06-3034.1M
Q1 '252025-03-3135.5M
Q4 '242024-12-3134.7M
Q3 '242024-09-3035.3M
Q2 '242024-06-3032.9M
Q1 '242024-03-3132.6M
Q4 '232023-12-3130.2M
Q3 '232023-09-3031M
Q2 '232023-06-3032.9M
Q1 '232023-03-3130.4M
Q4 '222022-12-3128.5M
Q3 '222022-09-3028.1M
Q2 '222022-06-3027.3M
Q1 '222022-03-3124.4M
Q4 '212021-12-3123.6M
Q3 '212021-09-3022.9M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-3.5M
Q1 '262026-03-313.2M
Q4 '252025-12-316.8M
Q3 '252025-09-308.3M
Q2 '252025-06-3010.8M
Q1 '252025-03-319.7M
Q4 '242024-12-312.8M
Q3 '242024-09-3012.2M
Q2 '242024-06-306.2M
Q1 '242024-03-3110.4M
Q4 '232023-12-315.5M
Q3 '232023-09-307.6M
Q2 '232023-06-307.7M
Q1 '232023-03-317.9M
Q4 '222022-12-317.3M
Q3 '222022-09-307.8M
Q2 '222022-06-30-85.6M
Q1 '222022-03-319.8M
Q4 '212021-12-315.9M
Q3 '212021-09-309M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-6.6M
Q1 '262026-03-312.3M
Q4 '252025-12-312M
Q3 '252025-09-308.2M
Q2 '252025-06-303.2M
Q1 '252025-03-3113.7M
Q4 '242024-12-313.7M
Q3 '242024-09-3010.7M
Q2 '242024-06-30-7.1M
Q1 '242024-03-31-4.2M
Q4 '232023-12-317.7M
Q3 '232023-09-307.5M
Q2 '232023-06-30-5.1M
Q1 '232023-03-31-6.8M
Q4 '222022-12-31447.5K
Q3 '222022-09-3015K
Q2 '222022-06-30-2.6M
Q1 '222022-03-311.2M
Q4 '212021-12-315.5M
Q3 '212021-09-303M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-3015.3M
Q1 '262026-03-3114M
Q4 '252025-12-3114.8M
Q3 '252025-09-3013.5M
Q2 '252025-06-3013.9M
Q1 '252025-03-3112.6M
Q4 '242024-12-3114M
Q3 '242024-09-3015.3M
Q2 '242024-06-3015.4M
Q1 '242024-03-3113.5M
Q4 '232023-12-3114M
Q3 '232023-09-3014.2M
Q2 '232023-06-3015.8M
Q1 '232023-03-3113.9M
Q4 '222022-12-3115.4M
Q3 '222022-09-3013.3M
Q2 '222022-06-3013.5M
Q1 '222022-03-3112.3M
Q4 '212021-12-3113.5M
Q3 '212021-09-3012.3M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-1.2M
Q1 '262026-03-313.9M
Q4 '252025-12-317.6M
Q3 '252025-09-3014.1M
Q2 '252025-06-307.1M
Q1 '252025-03-316.5M
Q4 '242024-12-3112.4M
Q3 '242024-09-3015.6M
Q2 '242024-06-309.9M
Q1 '242024-03-317.4M
Q4 '232023-12-317M
Q3 '232023-09-30160K
Q2 '232023-06-306.8M
Q1 '232023-03-3113M
Q4 '222022-12-316.1M
Q3 '222022-09-306.4M
Q2 '222022-06-30-28.6M
Q1 '222022-03-317M
Q4 '212021-12-3110.1M
Q3 '212021-09-306.3M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-3.7M
Q1 '262026-03-313.5M
Q4 '252025-12-316.5M
Q3 '252025-09-3013.6M
Q2 '252025-06-305.3M
Q1 '252025-03-314.8M
Q4 '242024-12-3110.7M
Q3 '242024-09-3014M
Q2 '242024-06-307.4M
Q1 '242024-03-316.7M
Q3 '232023-09-30-291K
Q2 '232023-06-306.8M
Q1 '232023-03-3112.9M
Q4 '222022-12-316M
Q3 '222022-09-306.4M
Q2 '222022-06-30-28.6M
Q1 '222022-03-316.7M
Q4 '212021-12-319.4M
Q3 '212021-09-306.1M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3028.6M
Q1 '262026-03-3136M
Q3 '252025-09-3036.7M
Q2 '252025-06-3031.7M
Q1 '252025-03-3137M
Q3 '242024-09-3032.3M
Q2 '242024-06-3033.1M
Q1 '242024-03-3134.6M
Q3 '232023-09-3031M
Q2 '232023-06-3020.7M
Q1 '232023-03-3117.6M
Q3 '222022-09-307.6M
Q2 '222022-06-307.6M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-300.11
Q1 '262026-03-310.44
Q4 '252025-12-310.75
Q3 '252025-09-300.78
Q2 '252025-06-300.89
Q1 '252025-03-310.58
Q4 '242024-12-310.09
Q3 '242024-09-300.53
Q2 '242024-06-300.44
Q1 '242024-03-310.40
Q4 '232023-12-310.13